Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04590820
Title Oral Tazemetostat in Combination With Rituximab in R/R FL
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Swedish Medical Center
Indications

follicular lymphoma

Therapies

Rituximab + Tazemetostat

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.